Mergers & Acquisitions - Teva Pharmaceutical Industries, Regulation

Filter

Popular Filters

Teva gets EU clearance for Cephalon acquisition; negative review on Azilect

14-10-2011

Following US antitrust clearance last week, Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA)…

AzilectCephalonMergers & AcquisitionsNeurologicalPharmaceuticalRegulationTeva Pharmaceutical Industries

Teva invests $7.5 million in Cocrystal Discovery for novel hepatitis C antiviral

18-09-2011

In a further move to boost its non-generics activities, Israel’s Teva Pharmaceutical Industries…

Anti-viralsCocrystal DiscoveryLicensingMergers & AcquisitionsPharmaceuticalRegulationTeva Pharmaceutical Industries

Company Spotlight

ImmunoGen

ImmunoGen

Back to top